Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHSBC Holdings Regulatory News (HSBA)

Share Price Information for HSBC Holdings (HSBA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 644.60
Bid: 610.00
Ask: 651.00
Change: 0.00 (0.00%)
Spread: 41.00 (6.721%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 644.60
HSBA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Base Prospectus Supplement

9 Jun 2021 17:00

RNS Number : 3843B
HSBC Holdings PLC
09 June 2021
 

 

 

HSBC HOLDINGS PLC

PUBLICATION OF BASE PROSPECTUS SUPPLEMENT

The following base prospectus supplement has been approved by the Financial Conduct Authority and is available for viewing:

Base Prospectus Supplement dated 9 June 2021 to the Base Prospectus dated 30 March 2021.

To view the full document, please paste the following URL into the address bar of your browser: http://www.hsbc.com/investors/fixed-income-investors/issuance-programmes

 A copy of the above document has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism 

 

 

Investor enquiries to:Greg Case +44 (0) 20 7992 3825 investorrelations@hsbc.com

 Media enquiries to:Ankit Patel +44 (0) 20 7991 9813 ankit.patel@hsbc.com

Note to editors:

HSBC Holdings plc

HSBC Holdings plc, the parent company of HSBC, is headquartered in London. HSBC serves customers worldwide from offices in 64 countries and territories in its geographical regions: Europe, Asia, North America, Latin America, and Middle East and North Africa. With assets of US$2,959bn at 31 March 2021, HSBC is one of the world's largest banking and financial services organisations.

 

 

DISCLAIMER - INTENDED ADDRESSEES

IMPORTANT: You must read the following before continuing: The following applies to the Base Prospectus Supplement available by clicking on the link above, and you are therefore advised to read this carefully before reading, accessing or making any other use of the Base Prospectus Supplement. In accessing the Base Prospectus Supplement, you agree to be bound by the following terms and conditions, including any modifications to them, any time you receive any information from us as a result of such access.

THE BASE PROSPECTUS SUPPLEMENT MAY NOT BE FORWARDED OR DISTRIBUTED OTHER THAN AS PROVIDED BELOW AND MAY NOT BE REPRODUCED IN ANY MANNER WHATSOEVER. THE BASE PROSPECTUS SUPPLEMENT MAY ONLY BE DISTRIBUTED OUTSIDE THE UNITED STATES TO PERSONS THAT ARE NOT U.S. PERSONS AS DEFINED IN, AND IN RELIANCE ON, REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT") OR WITHIN THE UNITED STATES TO QIBs (AS DEFINED BELOW) IN ACCORDANCE WITH RULE 144A UNDER THE SECURITIES ACT ("RULE 144A"). ANY FORWARDING, DISTRIBUTION OR REPRODUCTION OF THE BASE PROSPECTUS SUPPLEMENT IN WHOLE OR IN PART IS PROHIBITED. FAILURE TO COMPLY WITH THIS NOTICE MAY RESULT IN A VIOLATION OF THE SECURITIES ACT OR THE APPLICABLE LAWS OF OTHER JURISDICTIONS.

NOTHING IN THIS ELECTRONIC PUBLICATION CONSTITUTES AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO DO SO. ANY NOTES ISSUED OR TO BE ISSUED PURSUANT TO THE BASE PROSPECTUS RELATING TO THE HSBC HOLDINGS PLC DEBT ISSUANCE PROGRAMME (THE "BASE PROSPECTUS") AND THE BASE PROSPECTUS SUPPLEMENT HAVE NOT BEEN, AND WILL NOT BE, REGISTERED UNDER THE SECURITIES ACT OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES OR ANY OTHER JURISDICTION. ANY NOTES ISSUED OR TO BE ISSUED PURSUANT TO THE BASE PROSPECTUS AND THE BASE PROSPECTUS SUPPLEMENT MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT (1) IN ACCORDANCE WITH RULE 144A UNDER THE SECURITIES ACT TO PERSONS REASONABLY BELIEVED TO BE QUALIFIED INSTITUTIONAL BUYERS (EACH A "QIB") WITHIN THE MEANING OF RULE 144A OR (2) IN AN OFFSHORE TRANSACTION TO A PERSON THAT IS NOT A U.S. PERSON IN ACCORDANCE WITH RULE 903 OR RULE 904 OF REGULATION S UNDER THE SECURITIES ACT.

Please note that the information contained in the Base Prospectus Supplement may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus is not addressed. Prior to relying on the information contained in the Base Prospectus and the Base Prospectus Supplement you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

Confirmation of your Representation: In order to be eligible to view the Base Prospectus Supplement or make an investment decision with respect to any Notes issued or to be issued pursuant to the Base Prospectus and the Base Prospectus Supplement, you must be (i) a person other than a U.S. person (as defined in Regulation S under the Securities Act); or (ii) a QIB that is acquiring the securities for its own account or for the account of another QIB. By accessing the Base Prospectus Supplement, you shall be deemed to have represented that you and any customers you represent are not a U.S. person or that you are a QIB, and that you consent to delivery of the Base Prospectus Supplement and any supplements thereto via electronic publication.

You are reminded that the Base Prospectus Supplement has been made available to you on the basis that you are a person into whose possession the Base Prospectus Supplement may be lawfully delivered in accordance with the laws of the jurisdiction in which you are located and you may not, nor are you authorised to, deliver the Base Prospectus Supplement to any other person.

The Base Prospectus Supplement does not constitute, and may not be used in connection with, an offer or solicitation in any place where offers or solicitations are not permitted by law. If a jurisdiction requires that the offering be made by a licensed broker or dealer and the underwriters or any affiliate of the underwriters is a licensed broker or dealer in that jurisdiction, the offering shall be deemed to be made by the underwriters or such affiliate on behalf of HSBC Holdings plc in such jurisdiction. Under no circumstances shall the Base Prospectus Supplement constitute an offer to sell, or the solicitation of an offer to buy, nor shall there be any sale of any Notes issued or to be issued pursuant to the Base Prospectus and the Base Prospectus Supplement, in any jurisdiction in which such offer, solicitation or sale would be unlawful.

The Base Prospectus Supplement has been made available to you in an electronic form. You are reminded that documents transmitted via this medium may be altered or changed during the process of electronic transmission and consequently none of HSBC Holdings plc, its advisers, any person who controls HSBC Holdings plc or any director, officer, employee nor agent of HSBC Holdings plc or affiliate of any such person accepts any liability or responsibility whatsoever in respect of any difference between the Base Prospectus Supplement made available to you in electronic format and the hard copy version available to you on request from HSBC Holdings plc.

ends/all

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIUPUGWQUPGGAB
Date   Source Headline
18th Apr 20245:58 pmRNSTransaction in Own Shares
18th Apr 202410:00 amRNSOverseas Regulatory Announcement - Board Meeting
17th Apr 20246:15 pmRNSTransaction in Own Shares
16th Apr 20246:00 pmRNSTransaction in Own Shares
15th Apr 20246:24 pmRNSTransaction in Own Shares
15th Apr 20241:00 pmRNSFourth Interim Dividend for 2023 - Exchange Rate
12th Apr 20245:57 pmRNSTransaction in Own Shares
12th Apr 20243:35 pmRNSNotice of redemption
11th Apr 20246:25 pmRNSTransaction in Own Shares
11th Apr 202410:00 amRNSOverseas Regulatory Announcement - Grant of Awards
10th Apr 20246:09 pmRNSTransaction in Own Shares
9th Apr 20245:53 pmRNSTransaction in Own Shares
9th Apr 20247:00 amRNSHSBC AGREES TO SELL ITS BUSINESS IN ARGENTINA
8th Apr 20246:10 pmRNSTransaction in Own Shares
5th Apr 202410:00 amRNSDirector Declaration
4th Apr 20246:24 pmRNSTransaction in Own Shares
3rd Apr 20246:14 pmRNSTransaction in Own Shares
2nd Apr 20245:59 pmRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSCompletion of the sale of HSBC Bank Canada to RBC
28th Mar 20246:01 pmRNSTransaction in Own Shares
28th Mar 20244:30 pmRNSDirector/PDMR Shareholding
28th Mar 20244:00 pmRNSTotal Voting Rights
27th Mar 20245:58 pmRNSTransaction in Own Shares
27th Mar 20243:45 pmRNSPublication of base prospectus
26th Mar 20245:54 pmRNSTransaction in Own Shares
25th Mar 20245:58 pmRNSTransaction in Own Shares
22nd Mar 20245:50 pmRNSTransaction in Own Shares
22nd Mar 20242:00 pmRNSIssuance of subordinated unsecured notes
22nd Mar 202410:00 amRNS2024 AGM - Documents available at NSM
21st Mar 20246:03 pmRNSTransaction in Own Shares
21st Mar 202411:00 amRNSIssuance of subordinated unsecured notes
20th Mar 20245:51 pmRNSTransaction in Own Shares
20th Mar 202410:00 amRNSHong Kong Waiver-Contingent Convertible Securities
19th Mar 20245:46 pmRNSTransaction in Own Shares
19th Mar 202410:00 amRNSOverseas Regulatory Announcement - Grant of Awards
18th Mar 20245:54 pmRNSTransaction in Own Shares
18th Mar 202411:20 amRNSPre Stabilisation Notice
15th Mar 20246:20 pmRNSTransaction in Own Shares
14th Mar 20246:07 pmRNSTransaction in Own Shares
14th Mar 20245:02 pmRNSDirector/PDMR Shareholding
13th Mar 20246:20 pmRNSTransaction in Own Shares
13th Mar 20244:00 pmRNSDirector/PDMR Shareholding
12th Mar 20246:06 pmRNSTransaction in Own Shares
12th Mar 202411:00 amRNSIssuance of subordinated unsecured notes
11th Mar 20245:56 pmRNSTransaction in Own Shares
8th Mar 20246:19 pmRNSTransaction in Own Shares
7th Mar 20246:05 pmRNSTransaction in Own Shares
6th Mar 20245:57 pmRNSTransaction in Own Shares
5th Mar 20245:48 pmRNSTransaction in Own Shares
4th Mar 20245:55 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.